Search Results - "Ozharovskaia, Tatiana A"

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study by Tukhvatulin, Amir I., Dolzhikova, Inna V., Dzharullaeva, Alina S., Grousova, Daria M., Kovyrshina, Anna V., Zubkova, Olga V., Zorkov, Ilya D., Iliukhina, Anna A., Shelkov, Artem Y., Erokhova, Alina S., Popova, Olga, Ozharovskaia, Tatiana A., Zrelkin, Denis I., Izhaeva, Fatima M., Shcheblyakov, Dmitry V., Esmagambetov, Ilias B., Tokarskaya, Elisaveta A., Nikitenko, Natalia A., Lubenets, Nadezhda L., Khadorich, Elizaveta A., Gushchin, Vladimir A., Borzakova, Svetlana N., Vlasova, Anna V., Osmanov, Ismail M., Gorev, Valerii V., Naroditsky, Boris S., Logunov, Denis Y., Gintsburg, Alexander L.

“…To protect young individuals against SARS-CoV-2 infection, we conducted an open-label, prospective, non-randomised dose-escalation Phase 1/2 clinical trial to…”
Get full text

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults by Tukhvatulin, Amir I., Dolzhikova, Inna V., Shcheblyakov, Dmitry V., Zubkova, Olga V., Dzharullaeva, Alina S., Kovyrshina, Anna V., Lubenets, Nadezhda L., Grousova, Daria M., Erokhova, Alina S., Botikov, Andrei G., Izhaeva, Fatima M., Popova, Olga, Ozharovskaia, Tatiana A., Esmagambetov, Ilias B., Favorskaya, Irina A., Zrelkin, Denis I., Voronina, Daria V., Shcherbinin, Dmitry N., Semikhin, Alexander S., Simakova, Yana V., Tokarskaya, Elizaveta A., Shmarov, Maksim M., Nikitenko, Natalia A., Gushchin, Vladimir A., Smolyarchuk, Elena A., Zubkova, Tatiana G., Zakharov, Konstantin A., Vasilyuk, Vasiliy B., Borisevich, Sergei V., Naroditsky, Boris S., Logunov, Denis Y., Gintsburg, Alexander L.

“…While the world is experiencing another wave of COVID-19 pandemic, global vaccination program is hampered by an evident shortage in the supply of licensed…”
Get full text

In vitro and in vivo tropism and biodistribution of recombinant simian adenovirus type 25 by Vavilova, Irina V., Ozharovskaia, Tatiana A., Zubkova, Olga V., Popova, Olga, Voronina, Daria V., Goldovskaya, Polina P., Zrelkin, Denis I., Dzharullaeva, Alina Sh, Dolzhikova, Inna V., Shcheblyakov, Dmitry V., Logunov, Denis Yu, Gintsburg, Alexander L.

“…Introduction. Recombinant adenoviruses are widely used in the development of vaccines for a variety of infectious diseases. Despite numerous clinical studies,…”
Get full text

Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus by Gushchin, Vladimir A, Ogarkova, Darya A, Dolzhikova, Inna V, Zubkova, Olga V, Grigoriev, Igor V, Pochtovyi, Andrei A, Iliukhina, Anna A, Ozharovskaia, Tatiana A, Kuznetsova, Nadezhda A, Kustova, Daria D, Shelkov, Artem Y, Zrelkin, Denis I, Odintsova, Alina S, Grousova, Daria M, Kan, Vladislav Y, Davtyan, Sona A, Siniavin, Andrei E, Belyaeva, Elizaveta D, Botikov, Andrei G, Bessonova, Arina A, Vasilchenko, Lyudmila A, Vasina, Daria V, Kleymenov, Denis A, Slutskiy, Egor A, Tkachuk, Artem P, Burgasova, Olga A, Loginova, Svetlana Y, Rozhdestvensky, Evgeny V, Shcheblyakov, Dmitry V, Tsibin, Alexander N, Komarov, Andrey G, Zlobin, Vladimir I, Borisevich, Sergei V, Naroditsky, Boris S, Logunov, Denis Y, Gintsburg, Alexander L

“…WHO has declared the outbreak of monkeypox as a public health emergency of international concern. In less than three months, monkeypox was detected in more…”
Get full text